gemfibrozil has been researched along with Blood Clot in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil has shown beneficial effects as a lipid lowering agent; however, some proactivating effects on platelet function in vitro have been described." | 1.30 | Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk. ( Alfón, J; Badimon, L; Berrozpe, M; Gaffney, P; Palazón, CP; Royo, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, S | 1 |
| Sawa, H | 1 |
| Sobel, BE | 1 |
| Palazón, CP | 1 |
| Alfón, J | 1 |
| Gaffney, P | 1 |
| Berrozpe, M | 1 |
| Royo, T | 1 |
| Badimon, L | 1 |
| Sinzinger, H | 1 |
1 review available for gemfibrozil and Blood Clot
| Article | Year |
|---|---|
[Antilipemic agents and atherothrombosis. Effects of antilipemic agents on blood platelet function, coagulation and fibrinolysis].
Topics: Anticholesteremic Agents; Antiporters; Arteriosclerosis; Bezafibrate; Blood Coagulation; Blood Coagu | 1998 |
2 other studies available for gemfibrozil and Blood Clot
| Article | Year |
|---|---|
Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
Topics: Animals; Arteriosclerosis; Blood Proteins; Carcinoma, Hepatocellular; Cells, Cultured; Endothelium, | 1993 |
Effects of reducing LDL and increasing HDL with gemfibrozil in experimental coronary lesion development and thrombotic risk.
Topics: Animals; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Coronary Vessels; Fibrin; Gemf | 1998 |